We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
0 hedge funds and large institutions have $0 invested in Alder Biopharmaceuticals in 2019 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 143 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% less funds holding
Funds holding: 143 → 0 (-143)
100% less funds holding in top 10
Funds holding in top 10: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $1.75B → $0 (-$1.75B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 143
Holders
–
Holders Change
-143
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-8
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
143
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
RG
Redmile Group
San Francisco,
California
|
-$155M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$123M |
| 3 |
BlackRock
New York
|
-$120M |
| 4 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$84.7M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$78.6M |
